WHO ARE WE?. Any personal information provided to us will be controlled by Remitly Europe Limited of 7th Floor, Xxxxxxx Two, Xxxxxxx Dock, Cork, X00 XX00, Ireland who is the data controller (Remitly, we, us or our).
WHO ARE WE?. Charterprime Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) to provide financial product advice, deal and make a market in foreign exchange contracts and derivatives to retail and wholesale clients. Charterprime Pty Ltd is the holder of an AFSL 421210.
WHO ARE WE?. PROTECT is a multi-national consortium of 34 public and private partners including academics, regulators, SMEs and EFPIA companies with extensive experience in pharmacovigilance. In order to efficiently manage the PROTECT project, the research agenda was split into 7 sub-projects – work packages (WPs) which are complemented by a multi-layer management and governance structure including Consortium Assembly, Steering Committee and external expert group (External Advisory Board). Project coordination and management consists of (Deputy) Coordinator, PROTECT Management Support Team and Managing Entity of the IMI JU funding. The relationship between individual entities is shown in the diagram below. Managing Entity of IMI JU funding Steering Committee WP1 co-leaders = Coordinator & Deputy Coordinator WP2 co-leaders WP3 co-leaders WP4 co-leaders WP5 co-leaders WP6 co-leaders WP7 co-leaders WP 1 Management & Administration = PROTECT Management Support WP 2 Framework of PE studies WP 3 Methods for SD WP 4 WP 5 New tools for B/R integration & data collection representation WP 6 Validation studies WP 7 Training & communication External Advisory Board External independent experts Consortium Assembly All participants Seven WPs are subdivided into six scientific (each addressing one of the objectives above) and one managerial packages which are distinct from one another by their specific objectives, their methodologies, the type of data they use and the required expertise, but complimentary with regard to the overall project. These WPs can be described as • one WP concerned with the aspects of the organisation and management of PROTECT: WP1: Project management and administration • four “vertical” WPs targeting the specific scientific objectives and methodological developments WP2: Framework for PE studies WP3: Methods for signal detection WP4: New methods for data collection from consumers WP5: Benefit-risk integration and representation • two “horizontal” WPs concerned with the communication, validation and integration of the scientific work into an integrated and cohesive European activity WP7 Training & communication WPco-L: FICF, Novartis Pharma WP6 Validation studies involving an Extended Audience WPco-L: PGRx (LASER), SARD WP1 Project management & administration Coordinator: EMA Deputy Coordinator: GSK WP2 Framework for PE studies WPco-L: UU, Pfizer WP3 Methods for signal detection WPco-L: UMC, Bayer WP4 New tools for data collection WPco-L: EMA, HLU WP5 Benefit/r...
WHO ARE WE?. Any personal information provided to us will be controlled by Remitly (DIFC) Limited of DIFC who is the data controller (Remitly, we, us or our).
WHO ARE WE?. This website is controlled by Interfuse Limited a Company that is incorporated in England and Wales under company registration number 850109. Registered Head Office: Interfuse Ltd, 000 Xxxxxxxxxxxx Xxxx, Xxxxxxxxx. LE4 5PR Office telephone number: 0000 0000000 Facsimile number: 0116 2640259 Email address: xxxx@xxxxxxxxxxxxxxx.xxx VAT Registration Number: 115 0808 04
WHO ARE WE?. AxiCorp Financial Services Pty Ltd was established in 2008 to operate a foreign exchange business. It subsequently expanded its operations to include the issuing of other financial products that are the subject of our PDS, the delivery of services in respect of them and the development of platforms to facilitate the delivery of those services to Australian and international clients. AxiCorp is owned and supported by experienced and capable staff and investors which have provided the capital to expand and support its operations. AxiCorp is the holder of an Australian Financial Services Licence No 000000, which authorises it to: • provide financial product advice; • deal and make a market in foreign exchange contracts; and • deal and make a market in derivatives to retail clients.
WHO ARE WE?. The institution responsible for the processing of your personal data according to the data protection regulations is: Technische Informationsbibliothek (TIB) Welfengarten 1B 30167 Hannover Represented by:
WHO ARE WE?. MEX Digital Pty Ltd is incorporated under the Corporations Act 2001 (Commonwealth) and is under the jurisdiction of the Australian Securities and Investments Commission (“ASIC”) and registered with the Australian Transactions Reports and Analysis Centre (“AUSTRAC”) to operate as a digital asset exchange; enabling clients to make purchase and sale orders on our Platform. The Firm is owned and supported by an experienced and capable staff and investors which have provided the capital to expand and support its operations.
WHO ARE WE?. AxiCorp Financial Services Pty Ltd was established in 2008 to operate a foreign exchange business. It subsequently expanded its operations to include the issuing of other financial products that are the subject of our PDS, the delivery of services in respect of them and the development of platforms to facilitate the delivery of those services to Australian and international clients. AxiCorp is owned and supported by experienced and capable staff and investors which have provided the capital to expand and support its operations. AxiCorp is regulated by the New Zealand Financial Markets Authority (‘FMA’) in accordance with the Governing Legislation and is a Derivatives Issuer licence (‘DI Licence’) holder (FSP No. 518226) in respect of Transactions on financial markets.
WHO ARE WE?. AxiCorp Financial Services Pty Ltd has authorised Corporate Authorised Representatives (which are Companies) and Authorised Representatives (who are Individuals) to provide financial services. As the licensee, AxiCorp is responsible for the service you receive from our representatives and us. CMG Australia Pty Ltd. is authorised, as well as its nominated representatives, by AxiCorp to provide the following financial services to retail and wholesale clients: ▪ deal in foreign exchange contracts and derivatives; ▪ provide financial product advice in relation to foreign exchange contracts and derivatives; To the extent that we authorise our representative to do so, your adviser can help you to apply for the financial products referred to the above and can also give you general financial product advice in relation to them. If your adviser is unable or unwilling to provide you with advice or services in respect of certain products, the adviser will refer you to another representative of AxiCorp, who should be able to assist you.
